Join our community of smart investors

Idox endures “perfect storm”

A challenging 2017 saw higher revenues but significantly lower profits for the information management specialist
March 2, 2018

Idox’s (IDOX) disappointing - and delayed - results for the year to October 2017 stemmed from a “perfect storm of issues”, according to interim chief executive Richard Kellett-Clarke. Where to begin? The 2017 General Election caused customer disruption, meaning delayed sign-offs on some new contracts. The finance team also found that revenue from nine contracts should not be recognised within these full-year numbers. And, after Idox acquired healthcare business 6PM for £18.5m, various other issues emerged – requiring the restatement of 6PM’s accounts. As a result, costs tied to this acquisition significantly dampened the group’s bottom line.

IC TIP: Hold at 35.5p

While its problems occupied management’s time and resources, 6PM enabled Idox to create a new health segment. Over nine months, this achieved considerable sales of £7.6m. Meanwhile, the public sector software division – which accounts for nearly half of total revenues – won 108 new local authority customers and now serves 94 per cent of this market. Sales here were flat at £42m, partly due to electoral revenue facing a tough comparative with 2016’s EU referendum.

Separately, Idox announced that chief executive Andrew Riley is leaving due to ill health. Mr Kellett-Clarke continues in his role. Analysts at N+1 Singer forecast pre-tax profits of £15.6m and EPS of 2.9p for the year to October 2018, up from £12.1m and 2.3p in FY2017.

IDOX (IDOX)    
ORD PRICE:35.5pMARKET VALUE:£ 147m
TOUCH:34.6-36p12-MONTH HIGH:77pLOW: 26.5p
DIVIDEND YIELD:2.9%PE RATIO:54
NET ASSET VALUE:22p*NET DEBT:35%
Year to 31 OctTurnover (£m)Pre-tax profit (£m)Earnings per share (p)Dividend per share (p)
201357.37.52.400.70
201460.77.61.700.75
201562.69.82.200.85
201676.713.03.301.00
201788.93.50.661.04
% change+16-73-80+4
Ex-div:02 Apr   
Payment:20 Apr   
*Includes intangible assets of £123m or 29.6p per share